CARR Biosystems

CARR Biosystems is a global leader in designing and manufacturing high-quality centrifugal separation systems for bioprocessing. Founded in 1993, the company specializes in single-use centrifuges that support the scalable production of biological medicines and products in life sciences applications. CARR Biosystems has a strong focus on advancing life-saving solutions through its innovative equipment, which adheres to stringent safety and quality standards. The company offers a comprehensive portfolio of liquid/solid centrifugal separation systems, including the UniFuge® family of single-use centrifuges, the ViaFuge® for SIP/CIP applications, and the PowerFuge® high-performance systems. These products are designed for various applications, such as cell therapy, gene therapy, monoclonal antibodies, vaccines, and microbial fermentation. CARR Biosystems' technology enables high product recovery, minimal contamination risk, and flexibility for scaling processes from research to large-scale manufacturing.